Laurent Provins

This inventor holds 16 USPTO granted patents and 6 published patent applications, plus 3 CIPO patents and 12 EPO patents. Top assignees: Ucbbiopharma Srl, Ucb Pharma Gmbh, Ucb Pharma, S.a.. Active years: 2009-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Laurent Provins. Retrieved from https://idiyas.com/inventor/laurent-provins

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 16 (Patent Applications = 6)

% Patents Active = 68.8

CIPO Patents = 3 (Patent Applications = 12)

EPO Patents = 12 (Patent Applications = 18)

Average Co-Inventor Count = 3.6

ph-index = 2

Forward Citations = 6(Granted Patents)

Location History:

Soignies, BE (2009 - 2024)
Brussels, BE (2015 - 2024)

Company Filing History:

Years Active: 2009-2026

Loading Chart...

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12649754 - Prodrugs of 2-(3,5-dichloro-1-methyl-indazol-4-yl)-1-[(1S,3R)-3-(hydroxymethyl)-5-(1-hydroxy-1-methyl-ethyl)-1-methyl-3,4-dihydro-1H-isoquinolin-2-yl]ethanone (2026-06-09),

2. 12071404 - Aza (indole)-, benzothiophene-, and benzofuran-3-sulfonamides (2024-08-27),

3. 12006316 - 9H-pyrrolo-dipyridine derivatives (2024-06-11),

4. 11976056 - Substituted alkoxypyridinyl indolsulfonamides (2024-05-07),

5. 11939319 - Pyridinyl and pyrazinyl-(asa)indolsulfonamides (2024-03-26),

6. 11345662 - Aza (indole)-, benzothiophene-, and benzofuran-3-sulfonamides (2022-05-31),

7. 11312716 - 9H-pyrrolo-dipyridine derivatives (2022-04-26),

8. 11286266 - 1-imidazothiadiazolo-2H-pyrrol-5-one derivatives (2022-03-29),

9. 11155566 - 2-OXO-1-pyrrolidinyl imidazothiadiazole derivatives (2021-10-26),

10. 11155565 - 2-oxo-1,3-oxazolidinyl imidazothiadiazole derivatives (2021-10-26),

11. 11155564 - 2-oxo-1-imidazolidinyl imidazothiadiazole derivatives (2021-10-26),

12. 10889584 - Bicyclic bis-heteroaryl derivatives as modulators of protein aggregation (2021-01-12),

13. 10370355 - Tetrahydroisoquinoline derivatives (2019-08-06),

14. 8957218 - 2-oxo-1-imidazolidinyl imidazothiadiazole derivatives (2015-02-17),

15. 7943605 - Compounds comprising a lactam or a lactam derivative moiety, processes for making them, and their uses (2011-05-17),

Title: The Innovative Mind of Laurent Provins

Introduction

Laurent Provins, an esteemed inventor based in Brussels, Belgium, has made significant contributions to the field of pharmaceutical sciences. With an impressive portfolio of 15 patents, he has focused on developing innovative solutions for various central nervous system (CNS) diseases and disorders. His research reflects a deep commitment to improving healthcare and understanding complex medical conditions.

Latest Patents

Among Laurent's notable recent patents is his work on Aza (indole)-, benzothiophene-, and benzofuran-3-sulfonamides. This invention involves sulfonamide compounds with GPR17 modulating properties, which hold potential in treating or preventing a range of CNS diseases, particularly myelinating diseases or disorders. Furthermore, he has developed 9H-pyrrolo-dipyridine derivatives. This patent relates to these derivatives and includes processes for their preparation, pharmaceutical compositions featuring them, and their application as radiopharmaceuticals, specifically as imaging agents for detecting Tau aggregates.

Career Highlights

Laurent has significantly impacted the field through his tenure at UCB Biopharma SRL and UCB Pharma GmbH. His work in these prominent companies has allowed him to advance his research while collaborating with various experts in the pharmaceutical sector.

Collaborations

In his professional journey, Laurent has collaborated with noteworthy colleagues, including Hugues Chanteux and Marie Ledecq. Together, they have contributed to innovative research and developments in pharmaceuticals, enhancing their collective impact on science and medicine.

Conclusion

Laurent Provins stands as a testament to the spirit of innovation in the pharmaceutical industry. His dedication to advancing medical science through patents demonstrates his commitment to tackling critical health issues. As he continues to explore new horizons, the significance of his work will likely influence future breakthroughs in treating CNS disorders and beyond.

Profile summary based on public USPTO records.